The FDA approved a once-monthly dosing schedule for Rybrevant Faspro with Lazcluze for first-line treatment of EGFR-mutated advanced NSCLC, reducing clinic visits while maintaining safety and efficacy established with bi-weekly dosing.
The FDA approved Zycubo (copper histidinate) on January 13, 2026, as the first treatment for Menkes disease in pediatric patients, following resolution of manufacturing compliance concerns that led to an initial rejection in September 2025.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07585201 |
Dexmedetomidine Versus Nitroglycerin on Surgical Field Quality and Drug Cost in Functional Endoscopic Sinus Surgeries |
COMPLETED | NA |
| NCT07572539 |
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility Index for Predicting Hypotension in Patients Undergoing Shoulder Arthroscopy in Beach Chair Position: |
ACTIVE_NOT_RECRUITING | |
| NCT07565025 |
Internal Jugular Vein Collapsibility Index for Predicting Post-Induction Hypotension |
NOT_YET_RECRUITING | |
| NCT07551219 |
Effects of Ondansetron on Hemodynamic Changes After Spinal Anesthesia in Geriatric Urologic Surgery |
COMPLETED | |
| NCT07499947 |
Predicting Spinal Hypotension in Cesarean Section |
RECRUITING | |
| NCT07494955 |
"Effect of Pre-Spinal Mindfulness-Based Breathing Exercise on Hemodynamic Response in Elective Cesarean Section" |
RECRUITING | NA |
| NCT07481851 |
Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients |
RECRUITING | |
| NCT07433218 |
Frequency of Electrical Acupoint Stimulation on Hypotension During Induction |
NOT_YET_RECRUITING | NA |
| NCT07351552 |
The Effect of Frailty on Hypotension After Anesthesia Induction |
NOT_YET_RECRUITING | |
| NCT07348445 |
Clinical Trial of Digital Therapeutics (One.Dr) for Suspected Orthostatic Hypotension Patients |
NOT_YET_RECRUITING | NA |
